Alkem Laboratories
BSE: 539523 | NSE: ALKEM | ISIN: INE540L01014 | SECTOR: Biotechnology & DrugsOpen
3,322.30High
3,369.10Low
3,317.10Prev Close
3,303.15P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
400.41BVolume
1.36KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Biotechnology & Drugs
BSE
539523NSE
ALKEMISIN
INE540L01014
Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The Company operates through pharmaceuticals segment. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and approximately 50 countries internationally. The Company offers its products across various therapeutic areas, such as anti-infective, dermatology, diabetology, cardiology, gastroenterology, osteoporosis, Rheumatology, central nervous system (CNS), oncology, urology and gynecology. The Company offers its products under various brands, including Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Gemcal, Taxim, Sumo, Maxvoid Plus, Tamsukem Plus and Neurokem NT. The Company has approximately 20 manufacturing facilities, of which 18 manufacturing facilities are located in India and two in the United States.
Company Officers
Basudeo Singh
Executive Chairman of the BoardRajesh Dubey
Chief Financial Officer, President - FinanceManish Narang
President - Legal, Chief Compliance Officer, Company SecretarySandeep Singh
Managing Director, Executive DirectorMadhurima Singh
Executive DirectorMritunjay Singh
Executive DirectorSarvesh Singh
Executive DirectorSrinivas Singh
Executive Director